Care as usual
PreclinicalSmall molecule
Care as usual is one of 39 small molecule programs targeting Migraine. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
38
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
357 competitors in Migraine
#DrugCompanyPhaseTrials
1Savella
AbbViePreclinical
Botox
RRevance Therapeutics, Inc.
Preclinical
Cervidil
PfizerPreclinical
Adempas
BayerPreclinical
Viagra
VViatris Specialty LLC
Preclinical
Nitrostat
VViatris Specialty LLC
Preclinical
Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Preclinical
Botulinum Toxin a
GSKPreclinical
Lidocain
BayerPreclinical
Levcromakalim
DDanish Headache Center
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Migraine1 trial
Tertiary Care With or Without Manual Therapy for Chronic Migraine
Completed·—·N/A·NCT03395457·67 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Care as usual. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Southern Denmark